Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Glaxo Recently Made ‘Very Casual’ Overture to Genzyme, WSJ Says

GlaxoSmithKline Plc recently made a “very casual” overture to Genzyme Corp., asking the biotechnology company to keep it in mind if Genzyme considered selling itself, the Wall Street Journal reported, citing an unidentified person familiar with the matter.

The companies didn’t extend that dialogue, the newspaper said. Glaxo declined to comment, the Journal said.

Genzyme, which hasn’t decided whether it wants to sell itself, is considering an informal offer from Sanofi-Aventis SA, the newspaper said, citing unidentified people familiar with the matter.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.